Alzheimer’s Disease Clinical Study
This study is being done to evaluate the efficacy of a Pollypill comprised of Minocycline, atorvastatin, and sirolimus in treating mild to severe Alzheimers Disease. If you our a loved one feel suffer with Alzheimers this may be a solution for you. Call 813-796-6716 to speak with a clinician regarding your eligibility.

Meet your Doctor!
Dr. Richard B. Powell, MD., MPH
Dr. Richard Powell, M.D., M.P.H., is an experienced Principal Investigator dedicated to Alzheimer's disease research. He has led numerous clinical trials on disease-modifying and symptomatic treatments, adhering to FDA, GCP, and ICH guidelines. His on patient safety and ethical trial conduct drives his commitment to improving outcomes and advancing innovative approaches in Alzheimer's care.

About The Study
Eligibility Criteria
-
Must be between the ages of 50-85.
-
History of cognitive and functional decline for at least 1 year.
-
Diagnosis of mild-to-severe cognitive impairment or probable Alzheimer’s Disease.
-
Able to swallow a pill.
Study Overview
-
We are investigating a polypill in the treatment of Alzheimer's Disease.
-
This is a Phase 2b study.
-
The study is a 7-month long study with 10 visits spread out.
Location
1601 W Reynolds St, STE 203, Plant City, FL 33563

Benefits To Participating
Recieve Expert Medical Care
As a subject in a clinical trial, you will receive expert and quality medical attention from qualified physicians and staff which includes:
-
Testing for the APOEε4 gene – If you have this gene, you may have an increased risk of developing Alzheimer’s Disease
-
Study medication
Explore Novel Therapies & Advance Medicine
Participating in a clinical trial means that you may receive access to new and innovative therapies all the while you are helping to make the world a better place by ensuring better medicine is safe.
No Insurance - You Get Compensated!
Yup - you heard us right, participating in a clinical trial does not require insurance. In fact, qualified participants are eligible to receive compensation for their time and travel.
